IBM Total Assets

IBM · Total Assets

IBM logo

IBM Total Assets

Latest reported$152.10B
IBM Quarterly Total Assets ($52.63B → $152.10B)
High-resolution chart · PNG

IBM total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

IBM Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
152,099,000,000
156,229,000,000
151,880,000,000
146,312,000,000
148,585,000,000
145,667,000,000
137,175,000,000
134,339,000,000
133,848,000,000
137,169,000,000
135,241,000,000
129,321,000,000
132,213,000,000
133,637,000,000
127,243,000,000
125,850,000,000
127,503,000,000
133,275,000,000
132,001,000,000
144,214,000,000
146,814,000,000
148,629,000,000
155,971,000,000
154,128,000,000
154,200,000,000
153,403,000,000
152,186,000,000
149,620,000,000
154,652,000,000
130,926,000,000
123,382,000,000
121,990,000,000
121,622,000,000
125,285,000,000
125,356,000,000
121,636,000,000
120,495,000,000
117,495,000,000
117,470,000,000
115,606,000,000
118,056,000,000
118,856,000,000
110,495,000,000
108,649,000,000
112,729,000,000
112,037,000,000
117,532,000,000
118,911,000,000
124,314,000,000
122,646,000,000
126,223,000,000
117,845,000,000
115,153,000,000
117,258,000,000
119,213,000,000
115,778,000,000
113,832,000,000
115,347,000,000
116,433,000,000
110,158,000,000
113,474,000,000
112,960,000,000
113,452,000,000
107,174,000,000
103,420,000,000
105,208,000,000
109,022,000,000
103,675,000,000
103,655,000,000
101,944,000,000
109,524,000,000
115,910,000,000
120,928,000,000
121,823,000,000
120,431,000,000
108,609,000,000
102,548,000,000
101,619,000,000
103,234,000,000
104,155,000,000
103,377,000,000
102,468,000,000
105,748,000,000
101,009,000,000
103,388,000,000
104,899,000,000
109,183,000,000
100,676,000,000
99,582,000,000
101,825,000,000
104,457,000,000
97,190,000,000
96,938,000,000
95,720,000,000
96,484,000,000
83,956,000,000
84,211,000,000
83,056,000,000
88,313,000,000
85,094,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.